Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to assess the long term safety and efficacy of AeriSeal System treatment administered at up to 4 subsegments during a single treatment session for lung volume reduction in patients with advanced emphysema through 48 weeks after treatment.
Emphysema is a progressive, debilitating disease characterized by destruction of lung tissue as a result of inflammation caused by exposure to noxious inhaled agents for extended periods. The most common cause of this condition is cigarette smoking, although genetic, occupational, and environmental causes account for up to 10% of cases. Despite aggressive public health initiatives aimed at discouraging the use of cigarettes, smoking-related lung diseases remain a significant cause of disability and death worldwide. Due to the number of current and new smokers, emphysema is expected to remain a leading cause of morbidity and mortality for years to come.
The AeriSeal System is a novel device system being developed for the treatment of advanced emphysema. The AeriSeal System is administered bronchoscopically, and designed to provide the physiological benefits of lung volume reduction without the risks and cost of major surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AeriSeal System | Device | Not applicable. Follow-Up study only. |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in Percent Volume of Lung | Computed Tomography (CT) evidence of lobar volume reduction at site(s) of AeriSeal Foam Sealant administration at 48 weeks post treatment, assessed quantitatively by digital integration of CT dicom images collected using a standardized image acquisition and reconstruction algorithm. | 48 Weeks following treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Change in the ratio of Residual Volume (RV) to Total Lung Capacity (TLC) | Change from baseline at 24 and 48 weeks in RV/TLC | 24 and 48 weeks following treatment |
| Change in Forced Expiratory Volume in 1 Second (FEV1) |
Not provided
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Soroka Medical Center | Beersheba | 84101 | Israel | |||
| The Rabin Medical Center |
Not provided
| Label | URL |
|---|---|
| Aeris Therapeutics | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Change from baseline at 24 and 48 weeks in FEV1
| 24 and 48 weeks following treatment |
| Change in Forced Vital Capacity (FVC) | Change from baseline at 24 and 48 weeks in FVC | 24 and 48 weeks following treatment |
| Change in distance walked in six minutes | Change from baseline at 24 and 48 weeks in 6 Minutes Walk Test (6MWT) | 24 and 48 weeks following treatment |
| Change in Medical Research Council Dyspnea (MRCD) score | Change from baseline at 24 and 48 weeks in MRCD score | 24 and 48 weeks following treatment |
| Change in St. George's Respiratory Questionnaire (SGRQ)domain score | Change from baseline at 24 and 48 weeks in SGRQ total domain score | 24 and 48 weeks following treatment |
| Petah Tikva |
| 49100 |
| Israel |
| ID | Term |
|---|---|
| D011656 | Pulmonary Emphysema |
| D029424 | Pulmonary Disease, Chronic Obstructive |
| D008171 | Lung Diseases |
| D053120 | Respiratory Aspiration |
| D004646 | Emphysema |
| D010335 | Pathologic Processes |
| D012140 | Respiratory Tract Diseases |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D002908 | Chronic Disease |
| D020969 | Disease Attributes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012120 | Respiration Disorders |
Not provided
Not provided